Veranex today announced that it has acquired medtech design firm Worrell for an undisclosed amount.
Raleigh, N.C.-based Veranex delivers strategic, operations and financial benefits to medical device companies and engineers that are developing breakthrough technologies, according to the company. The acquisition of Worrell will expand its offerings and geographic reach.
“The addition of Worrell strengthens Veranex’s offerings as the leading global provider in the medical device and biotech space. By enhancing our human-centered design capabilities with a focus on Phase 0 strategy, design conceptualization, and human factors services, we complement our existing ISO-certified Phase 1-4 engineering and pilot-scale manufacturing capabilities,” Veranex executive chairperson Patrick Donnelly said in a news release. “We’re thrilled to welcome the employees of Worrell to Veranex.”
Worrell’s president Kai Worrell will join Veranex as president of its product development and engineering business.
“Worrell’s integration into Veranex comes at a perfect moment,” Kai Worrell said. “As medical device and biotech leaders around the world fuel their R&D pipelines, they need world class partners now more than ever. Adding Worrell’s 46 years of design expertise to the Veranex industry powerhouse will create new opportunities for improving global health outcomes.”
Veranex is the product of six complementary acquisitions that are backed by investor Summit Partners. The other acquisitions include Ximedica, Quartesian, Boston Healthcare Associates, Experien Group, IMM Recherche and Worrell.